BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32718848)

  • 1. Ki-67 labelling index is related to the risk classification and prognosis of gastrointestinal stromal tumours: a retrospective study.
    Wang JP; Liu L; Li ZA; Wang Q; Wang XY; Lin J
    Gastroenterol Hepatol; 2021 Feb; 44(2):103-114. PubMed ID: 32718848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki-67 labeling index may be a promising indicator to identify "very high-risk" gastrointestinal stromal tumor: a multicenter retrospective study of 1022 patients.
    Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
    Hum Pathol; 2018 Apr; 74():17-24. PubMed ID: 28962945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of gastrointestinal bleeding and expression of PTEN and Ki-67 on primary gastrointestinal stromal tumors.
    Wang H; Chen P; Liu XX; Zhao W; Shi L; Gu XW; Zhu CR; Zhu HH; Zong L
    World J Surg Oncol; 2014 Apr; 12():89. PubMed ID: 24712384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A correlation research of Ki67 index, CT features, and risk stratification in gastrointestinal stromal tumor.
    Li H; Ren G; Cai R; Chen J; Wu X; Zhao J
    Cancer Med; 2018 Sep; 7(9):4467-4474. PubMed ID: 30123969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and prognostic analysis of postoperative recurrence or metastasis of low-risk gastrointestinal stromal tumors.
    Cao L; Lin C; Liu Y; Sui C; Li Z; Chen L; Guan W; Tao L; Tao T; Wang M; Wang F
    World J Surg Oncol; 2024 Feb; 22(1):65. PubMed ID: 38395931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment of different risk classification systems for gastrointestinal stromal tumors (GISTs): the analytic results from the SEER database.
    Zhao B; Zhang J; Mei D; Zhang J; Luo R; Xu H; Huang B
    Scand J Gastroenterol; 2018; 53(10-11):1319-1327. PubMed ID: 30353759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Classification using the Ki-67 Labeling Index for Surgically-Treated Gastric Gastrointestinal Stromal Tumors.
    Miki Y; Kawamura T; Sugisawa N; Makuuchi R; Nakajima T; Tokunaga M; Tanizawa Y; Bando E; Terashima M
    Hepatogastroenterology; 2015 Jun; 62(140):919-23. PubMed ID: 26902028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of standardized AgNOR analysis and Ki-67 immunostaining in gastrointestinal stromal tumors.
    Rodolico V; Martorana A; Gulotta G; Diana G; Leonardi V; Cocorullo G; Ajello F
    Anal Quant Cytol Histol; 2003 Aug; 25(4):199-209. PubMed ID: 12961826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
    Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
    Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
    Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M
    Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
    Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
    J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of CT and EUS in the preoperative evaluation of gastric gastrointestinal stromal tumors larger than 2 cm.
    Chen T; Xu L; Dong X; Li Y; Yu J; Xiong W; Li G
    Eur Radiol; 2019 May; 29(5):2481-2489. PubMed ID: 30617491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A model to predict the recurrence of middle-high risk gastrointestinal stromal tumors based on preoperative fibrinogen and peripheral blood inflammatory indexes].
    Li W; Peng QW; Lin Y; Wan WZ; Zeng XY; Sun X; Yang WC; Xiong Z; Liu WZ; Tao KX; Zhang P
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):896-903. PubMed ID: 32927515
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognostic significance of Ki-67 expression in patients undergoing surgical resection for gastrointestinal stromal tumor].
    Jeong SY; Park WW; Kim YS; Park YI; Kim SH; Yoon WJ; Moon JS; Lee BM; Hong SW; Kang YK
    Korean J Gastroenterol; 2014 Aug; 64(2):87-92. PubMed ID: 25168050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors.
    Liang YM; Li XH; Li WM; Lu YY
    World J Gastroenterol; 2012 Apr; 18(14):1664-71. PubMed ID: 22529697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumors - quantitative detection of the Ki-67, TPX2, TOP2A, and hTERT telomerase subunit mRNA levels to determine proliferation activity and a potential for aggressive biological behavior.
    Kalfusova A; Hilska I; Krskova L; Kalinova M; Linke Z; Kodet R
    Neoplasma; 2016; 63(3):484-92. PubMed ID: 26952515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastrointestinal stromal tumors: clinical, pathologic features and effectiveness of new diagnostic criteria].
    Kim MK; Lee JK; Park ET; Lee SH; Seol SY; Chung JM; Kang MS; Yoon HK
    Korean J Gastroenterol; 2004 Jun; 43(6):341-8. PubMed ID: 15220551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-67 labeling index can be used as a prognostic marker in gastrointestinal stromal tumor: a systematic review and meta-analysis.
    Pyo JS; Kang G; Sohn JH
    Int J Biol Markers; 2016 May; 31(2):e204-10. PubMed ID: 26616229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods.
    Chen T; Xu L; Ye L; Qiu H; Hu Y; Liu H; Zhou Z; Li G; Yu J
    Eur J Surg Oncol; 2019 Jun; 45(6):1109-1114. PubMed ID: 30594406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors.
    Cai HX; Li XQ; Wang SF
    World J Gastroenterol; 2018 Nov; 24(44):5046-5056. PubMed ID: 30510379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.